Liu, X., Zhu, X., Feng, L., Li, X., Xu, B., Li, K., . . . Tang, Z. (2022). Physical activity improves outcomes of combined lenvatinib plus anti-PD-1 therapy in unresectable hepatocellular carcinoma: A retrospective study and mouse model. BMC.
Chicago Style (17th ed.) CitationLiu, Xue-Feng, et al. Physical Activity Improves Outcomes of Combined Lenvatinib Plus Anti-PD-1 Therapy in Unresectable Hepatocellular Carcinoma: A Retrospective Study and Mouse Model. BMC, 2022.
MLA (9th ed.) CitationLiu, Xue-Feng, et al. Physical Activity Improves Outcomes of Combined Lenvatinib Plus Anti-PD-1 Therapy in Unresectable Hepatocellular Carcinoma: A Retrospective Study and Mouse Model. BMC, 2022.
Warning: These citations may not always be 100% accurate.